Are Salivary Cytokines the Key to Early Detection of Oral Cancer?
Dr Gargi Roy Goswami
Content Marketing Strategist for Biotech & Health Startups I LinkedIn Top Voice I Founder, KROYNAS Digital l Dental Genetics & Saliva Research Influencer l Business Coach for Freelance Science Writers I Author
Oral squamous cell carcinoma (OSCC) poses a significant health challenge, with varying survival rates across different stages of diagnosis. Early detection remains crucial for improving patient outcomes, prompting researchers to explore innovative approaches for early diagnosis and prognostication.
One promising avenue involves the use of salivary biomarkers, particularly cytokines, to shed light on OSCC's pathogenesis and aid in early detection.
The Landscape of OSCC Diagnosis
The epidemiological landscape of OSCC reveals a stark contrast in survival rates across stages, emphasizing the need for more effective diagnostic tools.
Current research underscores the potential of salivary biomarkers, such as interleukins (IL-6, IL-8, IL-10, and IL-13), in enhancing our understanding of OSCC development and aggressiveness.
Salivary Cytokines: Key Players in OSCC Pathogenesis
Studies highlight the involvement of cytokines like IL-6, IL-8, VEGF, IL-1b, and TNF-α in the early stages of OSCC.
The identification of potential salivary biomarkers, including antibodies against IL-6 and p53, offers promising avenues for diagnosis.
However, challenges persist in standardizing methods, leading to variations in research outcomes.
IL-6: A Multifaceted Cytokine
IL-6 emerges as a pivotal cytokine with multifaceted functions, responding to various stimuli from different cells.
Its complex interplay with proinflammatory and anti-inflammatory cytokines in the tumour environment warrants further exploration.
While anti-inflammatory cytokines have been studied in other cancers, their role in OSCC remains a focal point for intensive research.
Saliva as a Diagnostic Ally
Saliva steps into the limelight as a diagnostic biofluid of choice, outshining blood and urine.
Salivary biomarkers present a promising frontier for future diagnostics, providing not just a snapshot of disease progression but also offering insights into potential recurrences!
领英推荐
IL-8: Bridging Inflammation and Cancer
IL-8, with its chemotactic activity for various immune cells, plays a crucial role in OSCC pathogenesis. Studies suggest its potential as a salivary biomarker, with elevated levels in OSCC patients compared to controls.
However, challenges in standardization and potential influences from other oral conditions require careful consideration.
IL-10: Balancing Act in OSCC
IL-10's anti-inflammatory and immunosuppressive functions make it a key player in OSCC.
Elevated levels in saliva have been associated with OSCC, but variations in study outcomes highlight the need for comprehensive investigations.
Challenges and Glimpses into the Future
Despite advancements in identifying salivary biomarkers, challenges such as standardization and differentiation from other conditions persist.
Future research should focus on
Refining diagnostic tools
Considering general health and oral statuses
Exploring the potential of salivary cytokines in disease monitoring and recurrence.
The Brighter Side
Oral cancer screening, coupled with salivary biomarkers, opens new perspectives for early OSCC diagnosis. IL-6, IL-8, IL-10, and IL-13 emerge as potential candidates, providing valuable insights into OSCC pathogenesis.
Do you think the integration of noninvasive approaches and the exploration of salivary cytokines can bring a paradigm shift in oral cancer diagnostics?
Inspired by:
Roi A, Roi CI, Negru?iu ML, Rivi? M, Sinescu C, Rusu LC. The Challenges of OSCC Diagnosis: Salivary Cytokines as Potential Biomarkers. J Clin Med. 2020 Sep 4;9(9):2866. doi: 10.3390/jcm9092866. PMID: 32899735; PMCID: PMC7565402.
MSc Infection Immunity and Human Disease from the University of Leeds | Dental Surgeon
11 个月I think it's an interesting approach. However, the problem lies in the clinical translation of these biomarkers. All predictive or diagnostic biomarkers should undergo rigorous analytical and clinical validation studies. I haven't thoroughly reviewed all the salivary cytokines clinical studies, but came across some poorly designed studies. I think one of the main issues is the lack of harmonized sample collection and processing protocols. For example a study published in nature, in 2020, collection, transportation and storage had a varying time frame of 1 to 4 hours without adding any protease inhibitors. There are studies that showed rapid protein degradation in saliva samples within 30 mins of collections. So, I think we should interpret these results with caution.
Oral and Maxillofacial Surgery | Surgical Techniques | Clinical Research: Oral Premalignant Disorders and Oral Cancer | Scientific Writing | Comprehensive Patient Care
11 个月Thanks Gargi.
Precision Medicine, Real-World Data / Evidence, immune system, multiomics and artificial intelligence (AI)
11 个月Dr Gargi Roy Goswami Thanks for sharing!